Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Lineage Cell Therapeutics Inc. (LCTX)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Broadwood Capital

Neal C. Bradsher

33,980,826 $37,379 +1% 4.67%
2. 95,000 $105 0.03%
3.
Millennium Management

Israel Englander

54,953 $60 0%
4. 0 $0 0%
5. 0 $0 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$0.00 0 Large Shareholder, Director 34,005,379 2019-08-15 Filing
$0.97 13,146 Large Shareholder, Director 34,005,379 2019-08-15 Filing
$0.00 0 Large Shareholder, Director 33,992,233 2019-08-14 Filing
$0.98 1,407 Large Shareholder, Director 33,992,233 2019-08-14 Filing
$0.00 0 Large Shareholder, Director 33,990,826 2019-08-13 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.80 150,000 Officer, Director 5,781,555 2017-07-31 Filing
$2.35 300,000 Large Shareholder, Officer, Director 5,638,055 2016-01-20 Filing
$3.83 100,000 Large Shareholder, Officer, Director 5,938,055 2015-11-06 Filing
$2.65 100,000 Officer 315,777 2014-07-22 Filing
$2.65 270,000 Officer, Director 875,987 2014-07-22 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 0 $0 0%
2. 0 $0 0%
3. 0 $0 0%
4. 0 $0 0%
5. 0 $0 0%